Effect of β-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans

K Sreekumaran Nair, S. L. Welle, D. Halliday, R. G. Campbell

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Because intravenous infusion of β-hydroxybutyrate (β-OHB) has been reported to decrease urinary nitrogen excretion, we investigated in vivo metabolism of leucine, an essential amino acid, using L-[1-13C]leucine as a tracer during β-OHB infusion. Leucine flux during β-OHB infusion did not differ from leucine flux during normal saline infusion in nine normal subjects, whereas leucine oxidation decreased 18-41% (mean = 30%) from 18.1 ± 1.1 μmol·kg-1·h-1 (P < 0.01), and incorporation of leucine into skeletal muscle protein increased 5-17% (mean = 10%) from 0.048 + 0.003%/h (P < 0.02). Since blood pH during β-OHB infusion was higher than the pH during saline infusion, we performed separate experiments to study the effect of increased blood pH on leucine kinetics by infusing sodium bicarbonate intravenously. Blood pH during sodium bicarbonate infusion was similar to that observed during the β-OHB infusion, but bicarbonate infusion had no effect on leucine flux or leucine oxidation. We conclude that β-OHB decreases leucine oxidation and promotes protein synthesis in human beings.

Original languageEnglish (US)
Pages (from-to)198-205
Number of pages8
JournalJournal of Clinical Investigation
Volume82
Issue number1
StatePublished - 1988
Externally publishedYes

Fingerprint

Hydroxybutyrates
Muscle Proteins
Leucine
Skeletal Muscle
Sodium Bicarbonate
Essential Amino Acids
Bicarbonates
Intravenous Infusions
Nitrogen

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of β-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. / Nair, K Sreekumaran; Welle, S. L.; Halliday, D.; Campbell, R. G.

In: Journal of Clinical Investigation, Vol. 82, No. 1, 1988, p. 198-205.

Research output: Contribution to journalArticle

@article{e62eca3dec954c269b8cb91bd4f9b01f,
title = "Effect of β-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans",
abstract = "Because intravenous infusion of β-hydroxybutyrate (β-OHB) has been reported to decrease urinary nitrogen excretion, we investigated in vivo metabolism of leucine, an essential amino acid, using L-[1-13C]leucine as a tracer during β-OHB infusion. Leucine flux during β-OHB infusion did not differ from leucine flux during normal saline infusion in nine normal subjects, whereas leucine oxidation decreased 18-41{\%} (mean = 30{\%}) from 18.1 ± 1.1 μmol·kg-1·h-1 (P < 0.01), and incorporation of leucine into skeletal muscle protein increased 5-17{\%} (mean = 10{\%}) from 0.048 + 0.003{\%}/h (P < 0.02). Since blood pH during β-OHB infusion was higher than the pH during saline infusion, we performed separate experiments to study the effect of increased blood pH on leucine kinetics by infusing sodium bicarbonate intravenously. Blood pH during sodium bicarbonate infusion was similar to that observed during the β-OHB infusion, but bicarbonate infusion had no effect on leucine flux or leucine oxidation. We conclude that β-OHB decreases leucine oxidation and promotes protein synthesis in human beings.",
author = "Nair, {K Sreekumaran} and Welle, {S. L.} and D. Halliday and Campbell, {R. G.}",
year = "1988",
language = "English (US)",
volume = "82",
pages = "198--205",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Effect of β-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans

AU - Nair, K Sreekumaran

AU - Welle, S. L.

AU - Halliday, D.

AU - Campbell, R. G.

PY - 1988

Y1 - 1988

N2 - Because intravenous infusion of β-hydroxybutyrate (β-OHB) has been reported to decrease urinary nitrogen excretion, we investigated in vivo metabolism of leucine, an essential amino acid, using L-[1-13C]leucine as a tracer during β-OHB infusion. Leucine flux during β-OHB infusion did not differ from leucine flux during normal saline infusion in nine normal subjects, whereas leucine oxidation decreased 18-41% (mean = 30%) from 18.1 ± 1.1 μmol·kg-1·h-1 (P < 0.01), and incorporation of leucine into skeletal muscle protein increased 5-17% (mean = 10%) from 0.048 + 0.003%/h (P < 0.02). Since blood pH during β-OHB infusion was higher than the pH during saline infusion, we performed separate experiments to study the effect of increased blood pH on leucine kinetics by infusing sodium bicarbonate intravenously. Blood pH during sodium bicarbonate infusion was similar to that observed during the β-OHB infusion, but bicarbonate infusion had no effect on leucine flux or leucine oxidation. We conclude that β-OHB decreases leucine oxidation and promotes protein synthesis in human beings.

AB - Because intravenous infusion of β-hydroxybutyrate (β-OHB) has been reported to decrease urinary nitrogen excretion, we investigated in vivo metabolism of leucine, an essential amino acid, using L-[1-13C]leucine as a tracer during β-OHB infusion. Leucine flux during β-OHB infusion did not differ from leucine flux during normal saline infusion in nine normal subjects, whereas leucine oxidation decreased 18-41% (mean = 30%) from 18.1 ± 1.1 μmol·kg-1·h-1 (P < 0.01), and incorporation of leucine into skeletal muscle protein increased 5-17% (mean = 10%) from 0.048 + 0.003%/h (P < 0.02). Since blood pH during β-OHB infusion was higher than the pH during saline infusion, we performed separate experiments to study the effect of increased blood pH on leucine kinetics by infusing sodium bicarbonate intravenously. Blood pH during sodium bicarbonate infusion was similar to that observed during the β-OHB infusion, but bicarbonate infusion had no effect on leucine flux or leucine oxidation. We conclude that β-OHB decreases leucine oxidation and promotes protein synthesis in human beings.

UR - http://www.scopus.com/inward/record.url?scp=0023722892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023722892&partnerID=8YFLogxK

M3 - Article

VL - 82

SP - 198

EP - 205

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -